Phase I Safety and Pharmacokinetics Study of Chiauranib in Patients With Advanced Solid Tumors

Trial Profile

Phase I Safety and Pharmacokinetics Study of Chiauranib in Patients With Advanced Solid Tumors

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Jun 2016

At a glance

  • Drugs Chiauranib (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors Chipscreen Biosciences
  • Most Recent Events

    • 16 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 29 Jan 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
    • 28 Jul 2015 Planned End Date changed from 1 Dec 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top